0000014272-20-000298.txt : 20201203
0000014272-20-000298.hdr.sgml : 20201203
20201203202423
ACCESSION NUMBER: 0000014272-20-000298
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201202
FILED AS OF DATE: 20201203
DATE AS OF CHANGE: 20201203
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: AHMED NADIM
CENTRAL INDEX KEY: 0001731193
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-01136
FILM NUMBER: 201368316
MAIL ADDRESS:
STREET 1: C/O CELGENE CORPORATION
STREET 2: 86 MORRIS AVENUE
CITY: SUMMIT
STATE: NJ
ZIP: 07901
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BRISTOL MYERS SQUIBB CO
CENTRAL INDEX KEY: 0000014272
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 220790350
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 430 E. 29TH STREET
STREET 2: 14 FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10016
BUSINESS PHONE: 2125464000
MAIL ADDRESS:
STREET 1: 430 E. 29TH STREET
STREET 2: 14 FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10016
FORMER COMPANY:
FORMER CONFORMED NAME: BRISTOL MYERS CO
DATE OF NAME CHANGE: 19891012
4
1
wf-form4_160704504862220.xml
FORM 4
X0306
4
2020-12-02
0
0000014272
BRISTOL MYERS SQUIBB CO
BMY
0001731193
AHMED NADIM
430 E. 29TH STREET
14TH FLOOR
NEW YORK
NY
10016
0
1
0
0
EVP and President, Hematology
Common Stock, $0.10 par value
2020-12-02
4
M
0
6594
0
A
34983
D
Common Stock, $0.10 par value
2020-12-02
4
F
0
3380
62.18
D
31603
D
Common Stock, $0.10 par value
1966
I
401(k)
Restricted Stock Units
2020-12-02
4
M
0
6594
0
D
2023-12-02
Common Stock, $0.10 par value
6594.0
19782
D
The restricted stock unit vests in four equal annual installments beginning on December 2, 2020.
Shares withheld for payment of taxes upon vesting of awards.
Based on recent plan statement.
Each restricted stock unit converts into one share of common stock upon vesting.
/s/ Lisa A. Atkins, attorney-in-fact for Nadim Ahmed
2020-12-03